HER2+ BREAST CANCER
Clinical trials for HER2+ BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER2+ BREAST CANCER trials appear
Sign up with your email to follow new studies for HER2+ BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart-Shield drugs tested for cancer patients
Prevention OngoingThis study tests whether two common heart medications can prevent heart damage in breast cancer patients receiving targeted therapy. Researchers want to see if giving carvedilol (a beta blocker) and/or empagliflozin (an SGLT2 inhibitor) alongside cancer treatment is safe and feas…
Matched conditions: HER2+ BREAST CANCER
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Apr 03, 2026 19:55 UTC
-
Blood test could guide when to stop breast cancer treatment
Knowledge-focused OngoingThis study is testing a personalized blood test to see if it can detect tiny traces of cancer in patients with advanced HER2-positive breast cancer who have responded very well to treatment for over two years. The goal is to gather knowledge that might help doctors decide if and …
Matched conditions: HER2+ BREAST CANCER
Sponsor: Nagoya City University • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC